what is glp-1 drugs for weight loss Medications: Everything You Need to Know Comparing GLP‑1 Drugs With Other

Angelman syndrome (AS) , characterized by microcephaly, seizures, motor dysfunction, and mental retardation, is a result of maternal chromosome deletions in the region 15q11-q13 associated with ubiquitin-protein ligase E3A (UBE3A) critical region [379] Angelman syndrome (AS) UBE3A encodes E6-associated protein (E6-AP), which acts as a cellular ubiquitin ligase and establishes a covalent linkage between a 76-amino acid ubiquitin molecule and its target protein to form a polyubiquitylated substrate [379]

Mitchell, S

Alzheimers disease treatment: the search for a breakthrough

Two-way ANOVA was used to analyze differences with two independent factors